Note 8 - Equity (Tables)

12 Months Ended

Dec. 31, 2021

Stockholders Equity Note [Abstract]

Summary of Stock-Based Award Activity

The following table summarizes the stock-based award activity under the Plan for the years ended December 31, 2021 and 2020.

	Restricted Stock Awards			Weighted-Average Grant Date Fair Value Per Restricted Stock Award
Outstanding as of December 31, 2019		—		$	—
Granted		153,200			0.55
Outstanding as of December 31, 2020		153,200			0.55
Granted		148,657			2.72
Vested		(56,451	)		2.95
Forfeited		(7,785	)		2.95
Outstanding as of December 31, 2021		237,621		$	1.26

Summary of Option Awards

In connection with the completion of the Initial Mergers, the Company assumed option awards previously issued to directors and officers of MedAmerica. Details of these options for the years ended December 31, 2021 and 2020, are presented in the table below:

	Number of Shares Underlying Options		Weighted Average Exercise Price Per Share		Weighted Average Fair Value at Grant Date		Weighted Average Remaining Contractual Life		Intrinsic Value
Balance at December 31, 2019		70,000	$	7.71	$	—		2.77	$	—
Options granted		—		—		—		—		—
Options exercised		—		—		—		—		—
Options expired		—		—		—		—		—
Balance at December 31, 2020		70,000	$	7.71	$	—		2.76	$	—
Options granted		—		—		—		—		—
Options exercised		—		—		—		—		—
Options expired		—		—		—		—		—
Balance at December 31, 2021		70,000	$	7.71	$	—		1.76	$	—